KromaTiD Announces Third U.S. Patent and New Proprietary Capabilities

KromaTiD Announces Third U.S. Patent and New Proprietary Capabilities Fort Collins, Colorado September 21, 2015:  With the issuance of its third U.S. patent (#9,090,935 B2), KromaTiD is pleased to announce an expansion of its full genome screening platform to include a new set of unique methods for understanding the structure of novel disease causing mutations.

KromaTiD Chosen to Present at 2015 Rocky Mountain Life Science Investor and Partnering Conference

KromaTiD Chosen to Present at 2015 Rocky Mountain Life Science Investor and Partnering Conference Fort Collins, Colorado – September 16, 2015:  KromaTiD, Inc. joins 29 other innovative life science companies from the Rocky Mountain region chosen to present at the 2015 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC). Representing Arizona, Colorado, Montana, New Mexico and […]

KromaTiD’s Dr. Susan Bailey Featured in NASA Effort to Study Long-Term Effects of Radiation Exposure

KromaTiD’s Dr. Susan Bailey Featured in NASA Effort to Study Long-Term Effects of Radiation Exposure Dr. Susan Bailey, Colorado State University professor in Radiobiology/Radiation Cancer Biology and co-founder of KromaTiD, is one of 10 scientists chosen by NASA to analyze blood from NASA’s year in space study involving astronaut twins Scott and Mark Kelly.

Houston…The Samples Have Landed!

Houston…The Samples Have Landed! NASA Twins Study investigator Susan Bailey, KromaTiD co-founder and Colorado State University Professor, and her team of researchers, Miles McKenna and Lynn Taylor, recently received their first samples from the International Space Station (ISS).  The samples are from NASA astronaut Scott Kelly, who is on the ride of his life; the […]

KromaTiD Signs Asian Distribution Agreement with Tokyo Future Style

Fort Collins, Colorado (PRWeb) May 18, 2015: KromaTiD is pleased to announce an agreement with Tokyo Future Style for distribution of its proprietary dGH™ and Pinpoint FISH™ products and services throughout Japan. Read more

KromaTiD Appoints tebu-bio as European Distributor

KromaTiD Appoints Tebu-Bio as European Distributor FORT COLLINS, CO (February 9, 2015) – KromaTiD, Inc. is pleased to announce that is partnering with tebu-bio for distribution of its proprietary dGH™ and Pinpoint FISH™ products and services throughout Europe. Headquartered in France, tebu-bio has offices in nine European countries and specializes in supplying innovative life science products and […]

KromaTiD Launches Genome Screening and Discovery Services

FORT COLLINS, CO (October 18th, 2014) – KromaTiD, Inc. is pleased to announce the launch of its directional Genomic HybridizationTM (dGHTM) screening services at the American Society of Human Genomics in San Diego October 18-22. Read more